Dinaciclib in Treating Patients With Stage IV Melanoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Thomas Jefferson University
Genmab
IDEAYA Biosciences
Seagen Inc.
Novartis
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
University of California, Davis
NYU Langone Health
The Methodist Hospital Research Institute
Mayo Clinic
Hoffmann-La Roche
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
University Health Network, Toronto
Sun Pharmaceutical Industries Limited
National Institutes of Health Clinical Center (CC)
Georgetown University
Genmab
H. Lee Moffitt Cancer Center and Research Institute
Replimune Inc.
M.D. Anderson Cancer Center
University Hospital, Basel, Switzerland
Erasca, Inc.
Erasca, Inc.
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Institute of Oncology Ljubljana
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center